Intrinsic Value of S&P & Nasdaq Contact Us

Inogen, Inc. INGN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.00
+310.1%

Inogen, Inc. (INGN) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Goleta, CA, United States. The current CEO is Kevin R. Smith.

INGN has IPO date of 2014-02-14, 766 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $172.65M.

About Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

📍 301 Coromar Drive, Goleta, CA 93117 📞 805 562 0500
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date2014-02-14
CEOKevin R. Smith
Employees766
Trading Info
Current Price$6.34
Market Cap$172.65M
52-Week Range5.34-9.13
Beta1.71
ETFNo
ADRNo
CUSIP45780L104
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message